The Sel1L-Hrd1 Endoplasmic Reticulum-Associated Degradation Complex Manages a Key Checkpoint in B Cell Development  by Ji, Yewei et al.
ArticleThe Sel1L-Hrd1 Endoplasmic Reticulum-Associated
Degradation Complex Manages a Key Checkpoint in
B Cell DevelopmentGraphical AbstractHighlightsd ERAD deficiency blocks the transition from large pre-B cells
to small pre-B cells
d ERAD manages a B cell developmental checkpoint by
attenuating pre-BCR signaling
d The pre-BCR complex is an endogenous Sel1L-Hrd1 ERAD
substrate in B cells
d Pre-BCR degradation by the Sel1L-Hrd1 complex requires
the ER chaperone BiPJi et al., 2016, Cell Reports 16, 2630–2640
September 6, 2016 ª 2016 The Author(s).
http://dx.doi.org/10.1016/j.celrep.2016.08.003Authors
Yewei Ji, Hana Kim, Liu Yang, Haibo Sha,
Christopher A. Roman, Qiaoming Long,
Ling Qi
Correspondence
lingq@med.umich.edu
In Brief
Ji et al. find that Sel1L-Hrd1 ERAD is
involved in B cell development through
regulation of proteasomal degradation of
the pre-B cell receptor complex.
Cell Reports
ArticleThe Sel1L-Hrd1 Endoplasmic Reticulum-Associated
Degradation Complex Manages a Key Checkpoint
in B Cell Development
Yewei Ji,1,5,6 Hana Kim,2,5,6 Liu Yang,1 Haibo Sha,1,7 Christopher A. Roman,3 Qiaoming Long,4 and Ling Qi1,2,6,8,*
1Division of Nutritional Sciences, Cornell University, Ithaca, NY 14853, USA
2Graduate Field of Immunology and Infectious Disease, Cornell University, Ithaca, NY 14853, USA
3Department of Cell Biology, College of Medicine and Program in Molecular and Cellular Biology, The School of Graduate Studies, State
University of New York, Downstate Medical Center at Brooklyn, New York, NY 11203, USA
4Laboratory Animal Research Center, Medical College of Soochow University, Suzhou 215006, Jiangsu, China
5Co-first author
6Present address: Department of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
7Present address: Cardiovascular & Metabolic Diseases, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA
8Lead Contact
*Correspondence: lingq@med.umich.edu
http://dx.doi.org/10.1016/j.celrep.2016.08.003SUMMARY
Endoplasmic reticulum (ER)-associated degradation
(ERAD) is a principal mechanism that targets ER-
associated proteins for cytosolic proteasomal degra-
dation. Here, our data demonstrate a critical role for
the Sel1L-Hrd1 complex, themost conserved branch
of ERAD, in early B cell development. Loss of Sel1L-
Hrd1 ERAD in B cell precursors leads to a severe
developmental block at the transition from large to
small pre-B cells. Mechanistically, we show that
Sel1L-Hrd1 ERAD selectively recognizes and targets
the pre-B cell receptor (pre-BCR) for proteasomal
degradation in a BiP-dependent manner. The pre-
BCR complex accumulates both intracellularly and
at the cell surface in Sel1L-deficient pre-B cells, lead-
ing to persistent pre-BCR signaling and pre-B cell
proliferation. This study thus implicates ERAD medi-
ated by Sel1L-Hrd1 as a key regulator of B cell devel-
opment and reveals the molecular mechanism un-
derpinning the transient nature of pre-BCR signaling.INTRODUCTION
Proteins destined for secretion or membrane localization are
folded in the endoplasmic reticulum (ER). Protein folding is a com-
plex, error-prone process that often results in the generation of
irreparable misfolded, often toxic, protein by-products. A strin-
gent quality control system is coupled to the protein folding pro-
cess, ensuring that only correctly folded proteins exit the ER to
proceed to their destination. ER-associated degradation (ERAD)
is a fundamental quality control mechanism responsible for the
recognition and translocation of terminally misfolded or unfolded
proteins in the ER, targeting them for cytosolic proteasomal
degradation (Olzmann et al., 2013). The use of artificial and dis-2630 Cell Reports 16, 2630–2640, September 6, 2016 ª 2016 The Au
This is an open access article under the CC BY-NC-ND license (http://ease-related mutant proteins as ERAD substrates has provided
important insights into ERAD biology (Guerriero and Brodsky,
2012); however, very little is known about the physiological impor-
tance of ERAD and the nature of its endogenous substrates.
The best-characterized ERAD machinery in mammals is the
highly conserved Sel1L-Hrd1 complex consisting of the E3 ubiq-
uitin ligase Hrd1 and its adaptor protein Sel1L (Olzmann et al.,
2013). Although many biochemical insights into ERAD biology
have been gained from the degradation of model substrates
such as immunoglobulin (Ig) light and heavy chains, the current
challenges are to identify the nature of its endogenous protein
substrates and to delineate the physiological relevance and sig-
nificance of ERAD in individual cell types in vivo. Using global
inducible Sel1L-deficient mouse models, we recently demon-
strated that Sel1L is a key component of the mammalian Hrd1
ERAD machinery by stabilizing the Hrd1 protein and that the
Sel1L-Hrd1 complex plays a critical role in the maintenance of
ER homeostasis and animal survival (Sun et al., 2014). Although
Sel1L-deficient mice are embryonic lethal (Francisco et al.,
2010), acute Sel1L deletion in adult mice results in pancreatic at-
rophy and premature lethality (Sun et al., 2014). In adipocytes,
Sel1L deficiency causes intracellular retention of lipoprotein
lipase, leading to hypertriglyceridemia (Sha et al., 2014). In the
small intestine, epithelial Sel1L-Hrd1 ERAD is indispensable for
the secretory function of Paneth cells and protects mice from
pathogen-induced ileitis (Sun et al., 2016), whereas, in the colon,
it modulates the progression of experimental colitis in part via
the degradation of IRE1a, the sensor of the unfolded protein
response (UPR) (Sun et al., 2015). However, the physiological
importance of Sel1L-Hrd1 ERAD in cell differentiation and devel-
opment has not been explored to date.
To this end, we chose to investigate B cell development as
a model system because of its complicated yet well-defined
and developmentally restricted expression of many growth
factors and cell surface-associated receptors required for
different stages of development. We reasoned that ERAD
may help reshape the membrane receptor proteome in B cellthor(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Reduced Peripheral B Lymphocyte Cellularity in Sel1LCD19 Mice
(A) RT-PCR analysis of ERAD genes in B cell subpopulations from BM of C57BL/6 mice.
(B) Growth curves for male littermates.
(C) Immunoblots of Sel1L, Hrd1, and BiP in CD19+ BM cells from Sel1Lf/f and Sel1LCD19 mice.
(D) Spleen mass.
(E) Flow cytometric analysis of mature B cells (B220+/IgM+) in the spleen, peripheral blood (PBL), and lymph nodes.
(F) Representative confocal microscopic images of B cells (red) in the spleen.
(G) Absolute numbers of splenic CD4+, CD8+ T, myeloid, and mature B cells.
Data are representative of two (A, C, and F) or three (E) independent experiments. n = 8 C57BL/6 mice (A), 18 mice each (B), 3 mice each (C), 15 Sel1Lf/f mice and
19 Sel1LCD19 mice (D), 3 mice each (F), and 8–9 mice each (E and G). Values are shown as mean ± SEM. N.S., not significant. *p < 0.05, ***p < 0.001 by two-tailed
Student’s t test. See also Figure S1.development. To reach the antibody-producing mature stage, B
cell precursors undergo a stepwise differentiation process in the
bone marrow (BM) from pro-B cells to cycling large pre-B cells,
resting small pre-B cells, and, finally, immature B cells. This pro-
cess requires a productive and sequential rearrangement of the
genes encoding Ig heavy (IgH or Igm) and light (IgL) chains that
form the B cell receptor (BCR). Prior to IgL chain rearrangement,
developing B cells express a set of B lineage-specific genes
called l5 (CD179b) and VpreB (CD179a), which form an IgL-
chain-like structure known as the surrogate light chain (SLC) to
pair with the Igm heavy chain to form the ‘‘pre-BCR’’ complex
(Clark et al., 2014; Herzog et al., 2009; Lee et al., 1999; Pillai
and Baltimore, 1987).
Here we found that Sel1L-Hrd1 ERAD manages a key check-
point at the transition from large to small pre-B cells. It does
so by targeting the pre-BCR complex for proteasomal degrada-
tion in a BiP-dependent manner, an event that is important for
the termination of pre-BCR signaling and, hence, differentiation.
Unexpectedly, Sel1L-Hrd1 ERAD has no effect on the turnover of
the BCR complex.
RESULTS
Reduced Peripheral B Cells in B Cell-Specific
Sel1L-Deficient Mice
Expression of the Sel1L andHrd1 genes was induced around the
pre-B cell stage in developing lymphocytes, preceding that of
the ER chaperones BiP and Edem1 (Figure 1A), suggesting a
possible role of Sel1L-Hrd1 ERAD in early lymphopoiesis. To
investigate whether Sel1L-Hrd1 ERAD plays a role in B cell
development, we crossed Sel1Lflox/flox (Sel1Lf/f) mice on theC57BL/6 background (Figure S1A) with CD19-Cre mice to
generate B cell-specific Sel1L-deficient mice (Sel1LCD19). The
CD19 promoter is active specifically in B cells and throughout
B cell development from the pro-B cell stage (Zhou et al.,
1991). The Sel1LCD19 mice and their control Sel1Lf/f littermates
were born in a normal Mendelian ratio (data not shown) and ap-
peared healthy with no obvious growth defects (Figure 1B).
Immunoblot analysis confirmed the deletion of the Sel1L protein
and reduction of Hrd1 protein in the BM-derived B cells (Fig-
ure 1C). Spleen weights were significantly reduced in Sel1LCD19
mice versus controls (Figure 1D; Figure S1B). The percentage of
peripheral B cells in the spleen, blood, and lymph nodes was
reduced by 60%–75% (Figure 1E), and the absolute numbers
of splenic B cells were >75% lower in Sel1LCD19 mice compared
with controls, whereas other cell types, including CD4+, CD8+
T cells, and myeloid cells were not affected (Figures 1F and
1G; Figure S1C). The reduction in B cells was not due to elevated
cell death (Figure S1D). Similar to the conventional BM B cells
(also known as B-2 cells), the percentage of peritoneal CD5+
B-1 cells was decreased in Sel1LCD19 mice versus Sel1Lf/f con-
trols (Figure S1E). Of note, there were 20% residual peripheral
B cells in the Sel1LCD19 mice, which is in line with the fact that
CD19-Cre-mediated deletion efficacy is approximately 75%–
80% in the early B cell compartment (Rickert et al., 1997). Hence,
we concluded that Sel1L is required for B cell development.
Developmental Defect at the Transition from the Large
to the Small Pre-B Cell Stage in Sel1LCD19 Mice
In adult BM, B lymphocytes develop from pluripotent hemato-
poietic stem cells through an ordered differentiation process
where Igm and IgL genes are sequentially rearranged and theCell Reports 16, 2630–2640, September 6, 2016 2631
Figure 2. Developmental Blockade at the Transition from Large to Small Pre-B Cells in Sel1LCD19 Mice
(A and B) Flow cytometric analysis of B220-CD43 (top) and B220-IgM (bottom) in BM cells from Sel1Lf/f and Sel1LCD19 mice (A), with quantitation in percentage
and absolute cell number shown in (B).
(C) Quantitation of flow cytometric analysis of various pro/pre-B cell populations in BM of Sel1Lf/f and Sel1LCD19mice. Original flow data are shown in Figure S2B.
Data are representative of three independent experiments with n = 9–10 mice each. Values are shown as mean ± SEM. *p < 0.05, ***p < 0.001 by two-tailed
Student’s t test. See also Figures S2 and S3.productive rearrangement of each establishes two key check-
points that test the functionality of each Ig component (Fig-
ure S2A). At the first checkpoint, Igm must form a signaling-
competent pre-BCR with the SLC. At the second checkpoint, a
functional BCR must be formed between Igm and a nascent IgL
after SLC expression is extinguished (Figure S2A). Consistent
with the reduced peripheral B cellularity in Sel1LCD19 mice,
B220high IgM+ recirculating mature and B220low IgM+ immature
B cells were significantly decreased in the BM of Sel1LCD19
mice versus Sel1Lf/f controls (Figures 2A and 2B). On the other
hand, the percentage of B220low CD43hi pro-B cells was slightly
elevated in Sel1LCD19 mice, whereas that of pre-B cells was
comparable with controls (Figures 2A and 2B). These data point
to a developmental defect at the pro/pre-B cell stage in
Sel1LCD19 mice. Pro/pre-B cells can be further classified based
on the expression of SLC and the differentiation marker CD2
(Figure S2A). Within the pro/pre- B cell compartment of the
BM, SLC+ CD2 pre-B I and large pre-B (II) cells were twice as
many, whereas SLC CD2+ small pre-B cells were reduced by
50% in Sel1LCD19 mice compared with Sel1Lf/f littermates (Fig-
ure 2C; Figure S2B). Cell death did not account for the changes
in B cell populations of Sel1LCD19 mice because apoptotic rates
for various precursor populations were comparable between the
cohorts (Figure S2C). Both Sel1L heterozygosity and CD19-Cre
expression as in Sel1Lf/+;CD19-Cre (Sel1LCD19/+) mice had no
effect on B cell development (Figure S2D), splenic B cell compo-2632 Cell Reports 16, 2630–2640, September 6, 2016sition (Figure S2E), and spleen weight (Figure S2F). Thus, B cell-
specific Sel1L deficiency results in a severe developmental
defect at the transition from large to small pre-B cells.
The Developmental Defect of Sel1LCD19 Mice Is
Independent of Chop
We hypothesized that impairment of an ER quality control system
like ERAD could activate a stress response, and that might ac-
count for the developmental block observed. Indeed, a subset
of ER stress-responsive genes such as BiP and Chop were
moderately elevated in large pre-B cells of Sel1LCD19 mice (Fig-
ure S3A). To determinemore directly the contribution of ER stress
in B cell development of Sel1LCD19 mice, we examined the role of
Chop in Sel1LCD19 mice by generating Sel1LCD19;Chop/ mice.
However, Chop deficiency had no effect on the B cell develop-
mental defects associated with the loss of Sel1L in terms of low
spleen weight (Figure S3B), paucity of the B cell compartment
within the peripheral lymphocyte pool (Figure S3C), and the devel-
opmental block at the large pre-B cell stage in the BM (Figures
S3D–S3G). Thus, B cell-specific Sel1L deficiency results in a
developmental block in a Chop-independent manner.
Selective Accumulation of the Pre-BCR in Large Pre-B
Cells
To explore the possible mechanism, we measured the protein
levels of various key factors involved in B cell development at
Figure 3. Accumulation of the Pre-BCR Complex in Sel1L-Deficient Large Pre-B Cells
(A) Schematic of various membrane receptors involved in early B cell development.
(B) Flow cytometric histogram analysis of BM cells from Sel1Lf/f and Sel1LCD19 mice, stained for total (surface and intracellular) levels of indicated proteins, gated
on B220lowIgM pro/pre-B cells. The gray-shaded area indicates isotype control.
(C) Flow cytometric analysis of BM cells from Sel1Lf/f and Sel1LCD19 mice stained for B220 and intracellular (ic) VpreB gated on pro/pre-B cells.
(D) Flow cytometric analysis of BM for ic-l5 and ic-VpreB in pro/pre-B cells with quantitation shown on the right.
(E) Flow cytometric analysis of BM for ic-l5 and ic-Igm in pro/pre-B cells with quantitation shown on the right.
(F) Flow cytometric histogram analysis of CD2, ic-Igm, and ic-l5 in various early B cell populations in BM. The gating strategy for each population (1–3) is shown on
the left.
Data are representative of four (B) or two (C–F) independent experiments. n = 18 mice each (B), 7 mice each (C), 7 mice each (D), 11-12 mice each (E), and 9 mice
each (F). Values are shown as mean ± SEM. ***p < 0.001 by two-tailed Student’s t test. See also Figure S4.the pre-B cell stage, including c-Kit, IL-7Ra, CD19, and the pre-
BCR complex (Clark et al., 2014; Herzog et al., 2009). All of these
factors are transmembrane proteins synthesized in the ER (Fig-
ure 3A). Although the total levels (intracellular and surface) of
c-Kit and IL-7Ra protein were comparable, the protein levels of
three main components of the pre-BCR complex were dramati-
cally increased in the pro/pre-B cells of Sel1LCD19 mice (Fig-
ure 3B). The percentage of SLC+ cells was significantly
increased in Sel1LCD19 BM (Figure 3C; Figure S4A). Accumula-
tion of the two SLC components VpreB and l5 occurred within
the same cells (Figure 3D). Moreover, because expression of
SLC precedes that of the Igm heavy chain (Kudo et al., 1992;
Lassoued et al., 1996), there is a l5+Igm pre-B I cell stage, in
addition to l5+ Igm+ large pre-B cells (Figure S2A). Strikingly,
we observed a 3-fold increase in the percentage of l5+ Igm+ large
pre-B cells in Sel1LCD19 mice compared with that of Sel1Lf/f
mice, whereas the percentage of l5+ Igm pre-B I cells was not
affected by ERAD deficiency (Figure 3E). In line with this finding,
measurement of l5 and Igm at different developmental stages re-
vealed their accumulation only in large pre-B cells when both
were co-expressed (Figure 3F). These data demonstrate that
Sel1L-Hrd1 ERAD recognizes and degrades the pre-BCR com-
plex rather than its individual components. Indeed, using apre-BCR complex-specific antibody, we found that the pro-
portion of pre-BCR complex-positive cells was doubled in
Sel1LCD19 BM (Figure S4B). Both qPCR and RT-PCR analyses
revealed comparable transcript levels of the VpreB, l5, and Igm
genes (Figures S4C and S4D), suggesting that pre-BCR protein
accumulation is a result of post-transcriptional regulation.
Hence, our data identify the pre-BCR complex, rather than its
individual components, as the possible Sel1L-Hrd1 ERAD sub-
strate in developing B cells.
The Pre-BCR Complex Is an Endogenous Sel1L-Hrd1
ERAD Substrate
We next directly tested whether the pre-BCR is an ERAD sub-
strate in pre-B cells. The protein levels of Igm, l5, and VpreB
were significantly stabilized in the BM of Sel1LCD19 mice
compared with Sel1Lf/f mice (Figure 4A; Figure S5A). By
contrast, IL-7Ra protein stability was not affected (Figure 4A;
Figure S5B). To further corroborate these findings in vitro, we
generated Sel1L- or Hrd1-deficient pre-BCR-expressing pre-B
cells, 70z/3 (Paige et al., 1978), using the RNAi and clustered
regularly interspaced short palindromic repeats (CRISPR)/cas9
systems, respectively (Figures 4B and 4C). Loss of either Sel1L
or Hrd1 in 70z/3 cells increased the steady-state protein levelsCell Reports 16, 2630–2640, September 6, 2016 2633
Figure 4. The Pre-BCR Complex Is an Endogenous Sel1L-Hrd1 ERAD Substrate
(A) Protein turnover for intracellular l5, VpreB, and Igm expression in fresh BM of Sel1Lf/f and Sel1LCD19 mice treated with 50 mg/ml cycloheximide (CHX) for the
indicated times. IL-7R, a control membrane protein.
(B and C) Immunoblot analysis of WT, Sel1L KD (KD) (B), and Hrd1/ (C) 70Z/3 pre-B cells with quantitation (normalized to HSP90) shown below each gel.
(D) Pulse-chase analysis showing Igm decay in WT and KD pre-B cells with quantitation shown on the right.
(E) Pulse-chase analysis showing Igm decay in WT pre-B cells treated with or without 25 mM MG132 for 0.5 hr with quantitation shown on the right.
(F) Immunoblot analysis of Igm immunoprecipitates in WT and Hrd1/ pre-B cells treated with or without 25 mMMG132 for 3 hr. Quantitation of Igm ubiquitination
(with or without normalization to total Igm) is shown below the blot.
Data are representative of two (A, D, and E), three (B and C), and four (F) independent experiments. n = 3 mice each (A). See also Figure S5.of all three components of the pre-BCR complex (Figures 4B and
4C) and led to Igm protein stabilization, with its half-life increasing
from approximately 60 min to over 120min (Figure 4D). Inhibition
of proteasomal activity using MG132 or bortezomib significantly
increased Igm protein stability in 70z/3 cells (Figure 4E and data
not shown), implicating the proteasome in pre-BCR degradation.
Furthermore, ubiquitination of Igm protein was reduced dramati-
cally in Sel1L/ or Hrd1/ 70z/3 cells (Figure 4F and data not
shown), pointing to the indispensable role of Sel1L-Hrd1 ERAD
in pre-BCR ubiquitination and degradation. Thus, we concluded
that Sel1L-Hrd1 ERAD recognizes and targets the pre-BCR
complex for ubiquitination and proteasomal degradation and
that Sel1L-Hrd1 ERAD deficiency leads to intracellular accumu-
lation of the pre-BCR.
Enhanced ER Exit of the Pre-BCR in Sel1L-Deficient
Pre-B Cells
We next determined the effect of Sel1L-Hrd1 ERAD deficiency
on pre-BCR complex formation and intracellular trafficking.
The accumulated pre-BCRs remained largely soluble (Figure 5A),
colocalized with the ER chaperone BiP (Figure 5B), and exhibited
a similar sensitivity to trypsin digestion in ERAD-deficient 70z/3
cells (Figure S6A). These data suggest that, in the case of pre-
BCR, Sel1L-Hrd1 ERAD deficiency does not trigger a dramatic
conformational change and, hence, protein aggregation. More-
over, accumulation of Igm and SLCs in ERAD-deficient 70z/3
pre-B cells increased the abundance of the high-molecular-2634 Cell Reports 16, 2630–2640, September 6, 2016weight pre-BCR complexes, as revealed by non-reducing
SDS-PAGE (left two lanes, Figure S6B) and sucrose density
gradient fractionation analyses (Figure 5C). Moreover, although
the majority of Igm protein in wild-type (WT) pre-B cells was re-
tained in the ER and exhibited high mannose endoglycosidase
(Endo) H sensitivity, as reported previously (Brouns et al.,
1996), Sel1L deficiency resulted in a nearly 3-fold increase in
Endo H-resistant and peptide-N-glycosidase F (PNGase F)-sen-
sitive Igm protein, indicative of increased ER exit of the pre-BCR
complex in the absence of Sel1L-Hrd1 ERAD (Figure 5D).
Consistently, more surface pre-BCR complexes were detected
in ERAD-deficient pre-B cells (Figure 5E) or pre-B cells treated
with the proteasome inhibitor MG132 (Figure 5F). Thus, impaired
pre-BCR degradation by Sel1L-Hrd1 ERAD leads to elevated
surface pre-BCR in pre-B cells.
Persistent Pre-BCR Signaling and Pre-B Cell Cycling in
Sel1LCD19 Mice
We next tested whether elevated surface pre-BCR results in
augmented pre-BCR signaling, consequently inducing a burst
of proliferation of large pre-B cells. Phosphorylation of the pre-
BCR key downstream effector spleen tyrosine kinase (Syk) (Her-
zog et al., 2009) was significantly increased in ERAD-deficient
pre-B cells (Figure 5G), as was overall tyrosine phosphorylation
(Figure S6C). Furthermore, the total number of BrdU-positive
cycling pro/pre-B cells in BM was increased by more than
50% in Sel1LCD19 mice compared with Sel1Lf/f mice (Figure 5H;
Figure 5. ERAD Is Indispensable for the Termination of Pre-BCR Signaling in Developing B Cells
(A) Immunoblot analysis of Igm in the NP-40 soluble (S) and insoluble (P) fractions of WT and Sel1L KD pre-B cells. The distribution of Bag6 and H2A marks the S
and P fractions, respectively.
(B) Confocal microscopic images of Igm (red) and BiP (green) staining in WT and Hrd1/ 70z/3 cells counterstained with DAPI.
(C) Sucrose gradient followed by immunoblot analysis of Igm in WT and KD pre-B cells under non-reducing and reducing conditions.
(D) Immunoblot analysis of Igm in WT and KD pre-B cell lysates treated with Endo H or PNGase F. (r, s = Endo H-resistant, sensitive). Quantitation of total Igm and
Endo H (r) Igm is shown below the blot.
(E and F) Quantitation of mean fluorescent intensity (MFI) of surface pre-BCR components in (E) WT and KD pre-B cells and (F) WT pre-B cells treated with or
without 25 mM MG132 for 2 hr.
(G) Western blot analysis of phospho-(pSyk) and total Syk (Syk) of WT and KD cells cross-linked with a-Igm (10 mg/ml) for the indicated times, with quantitation
shown on the right.
(H) Quantitation of flow cytometric analysis of BrdU incorporation in pro/pre-B cells and l5+ or l5 pro/pre-B cells of Sel1Lf/f and Sel1LCD19 mice, with original
flow data shown in Figure S6D.
Data are representative of two to three independent experiments. n = 6 mice each for (H). Values are shown as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 by
two-tailed Student’s t test. See also Figure S6.Figure S6D). Among them, only l5+ large pre-B cells were highly
proliferative in Sel1LCD19 mice, increasing more than 2.5-fold,
whereas l5 pro-B cell proliferation did not increase in
Sel1LCD19mice. Intriguingly, proliferation of Sel1L-deficient large
pre-B cells was over 2-fold higher than that of WT pre-B cells
when stimulated with IL-7 (Figures S6E and S6F), suggesting
that Sel1L effects on the pre-B compartment may not be
restricted to pre-BCR signaling and may include IL-7R signaling.
Thus, Sel1L deficiency in B cells leads to elevated and sustained
pre-BCR signaling and persistent proliferation of large pre-B
cells. In aggregate, these findings demonstrate that Sel1L-
Hrd1 ERAD is required to attenuate pre-BCR signaling by pro-
moting its protein turnover.
Sel1L-Hrd1 ERAD Degrades the Pre-BCR, Not the BCR,
Complex
In the pre-BCR, SLC and Igm assemble into a quaternary struc-
ture reminiscent of the BCR, with VpreB and l5 equivalent to
the variable and constant regions (VL and CL), respectively, of
IgL (Figure 6A). We compared how Sel1L-Hrd1 ERAD targets
pre-BCR for degradation by comparing the effect of ERAD on
the pre-BCR versus the BCR both in vitro and in vivo. Upon over-
night LPS stimulation, 70z/3 pre-B cells differentiated into
mature B cells expressing the BCR with a conventional k chainreplacing the SLC (Figures S6G and S6H), as reported previously
(Paige et al., 1978). This unique feature allowed us to determine
how ERAD affects the trafficking and stability of the pre-BCR
versus BCR complexes containing the same Igm heavy chain in
the same cell. Unlike Igm in the pre-BCR, neither the steady-state
protein level nor the stability of Igm in the BCR complex nor its
Endo H sensitivity (i.e., ER exit) were affected by Sel1L-Hrd1
ERAD deficiency in mature B cells (Figures 6B–6D). This was
not due to the lack of expression of ERAD components in mature
B cells because Sel1L and Hrd1 expression levels were compa-
rable between pre- and mature B cells (Figure 6E).
To further test this in vivo, we analyzed mature splenic B cells
from Sel1l-inducible knockout (Sel1LERCre) mice expressing es-
trogen receptor-Cre recombinase fusion protein (ERCre) under
the control of the actin promoter (Sun et al., 2014; Figure 6F).
Consistent with our in vitro observations, both intracellular Igm
and surface BCR (IgM) levels were comparable between
Sel1Lf/f and Sel1LERCre mature B cells (Figure 6G). Moreover,
plasma cell differentiation, cell size, and total IgG levels in LPS/
IL-4-treated mature primary B cells (Sel1Lf/f and Sel1LERCre)
were not affected by Sel1L deficiency (Figures S7A–S7C).
Indeed, Igm interactedwith several components of the ERADma-
chinery, including Sel1L and OS9, to a greater extent in pre-B
cells compared with mature B cells (Figure 6H). Therefore, weCell Reports 16, 2630–2640, September 6, 2016 2635
Figure 6. Sel1L-Hrd1 ERAD Degrades the Pre-BCR, but Not the BCR, Complex
(A) Diagram depicting the difference between BCR and pre-BCR complexes.
(B) Immunoblot analysis of Igm inWT and Sel1L KD cells (KD) treatedwith or without 20 mg/ml of lipopolysaccharide (LPS) for 18 hr, with quantitation shown below.
(C) Pulse-chase analysis showing Igm decay in WT and KD 70Z/3 cells treated with or without 20 mg/ml of LPS for 18 hr.
(D) Immunoblot analysis of Igm in WT and KD B cell lysates treated with Endo H or PNGase F. r/s, Endo H-resistant/sensitive). Quantitation of total Igm and Endo H
resistant (R) Igm is shown below the blot.
(E) Immunoblot analysis of ERAD proteins in WT and Hrd1/ 70z/3 pre-B cells treated with or without 20 mg/ml LPS for 18 hr.
(F) Western blot analysis of CD19+ splenic B cells isolated from WT and Sel1l-inducible knockout (Sel1LERCre) mice.
(G) Histogram analysis of surface IgM and ic Igm in splenic B cells of WT and Sel1LERCre mice (n = 3 mice each).
(H) Immunoblot analysis of immunoprecipitates of Igm-agarose in pre-B 70z/3 and mature B cells. One representative of two independent experiments is shown.
See also Figure S7.concluded that the pre-BCR, but not the BCR, complex is an
endogenous Sel1L-Hrd1 ERAD substrate.
Pre-BCR ERAD Requires BiP but Is Independent of the
Unique Region of l5
Because BiP is involved in the folding and intracellular trafficking
of the pre-BCR complex (Minegishi et al., 1999b), we first tested
whether BiP is required for pre-BCR ERAD. Depletion of BiP with
the subtilase cytotoxin SubAB (Paton et al., 2006) significantly
reduced the interaction between Igm and Sel1L (Figure 7A) and
stabilized Igm protein (Figure 7B). Moreover, given that the pre-
BCR and BCR complexes share the common Igm heavy chain,
we speculated that a key determinant in pre-BCR recognition
by ERAD may lie in the binding of SLC to Igm. We noted previous
reports demonstrating that the unique region of l5 (Figure 7C),
which is a non-Ig portion and does not pair with either VpreB
or Igm (Clark et al., 2014; Herzog et al., 2009), is known to retain
the pre-BCR complex in the ER (Fang et al., 2001; Minegishi
et al., 1999b; Ohnishi and Melchers, 2003). To determine the
role of the unique region of l5 in pre-BCR degradation, we ex-
pressed WT l5 and mutant l5 lacking the unique region (JC
l5, with only the J and C parts of l5) (Ohnishi and Melchers,
2003) in WT and Hrd1/ pre-B cells (Figure 7D). Surprisingly,
JC l5 expression had no effect on total steady-state intracellular2636 Cell Reports 16, 2630–2640, September 6, 2016levels of the pre-BCR complex in both WT and Hrd1/ pre-B
cells compared with those expressing WT l5 (Figure 7E; Fig-
ure S7D). Moreover, total pre-BCR complex levels were higher
in Hrd1/ pre-B cells than in those of WT cells expressing JC
l5 (Figure 7E), suggesting that the JC l5-containing pre-BCR
complex remains to be an ERAD substrate. Consistently, JC
l5 expression failed to affect Igm protein half-life (Figure 7F).
On the other hand, JC l5 increased surface pre-BCR in WT
pre-B cells, as reported previously (Fang et al., 2001; Minegishi
et al., 1999b; Ohnishi and Melchers, 2003; Figure S7E). Hence,
we concluded that BiP, but not the unique region of l5, is
required for recognition of the pre-BCR complex as an ERAD
substrate in pre-B cells.
DISCUSSION
This study shows that Sel1L-Hrd1 ERAD manages a key check-
point in B cell development by selectively targeting the pre-BCR
complex for proteasomal degradation. Indeed, the Sel1L-Hrd1
ERAD complex is indispensable for the termination of pre-BCR
signaling. B cell-specific deficiency of the Sel1L-Hrd1 ERAD sys-
tem blocks developmental progression at the large to small pre-
B cell transition. Surprisingly, we show that the pre-BCR, not
BCR, complex is an endogenous Sel1L-Hrd1 ERAD substrate
Figure 7. Sel1L-Hrd1 ERAD-Mediated Pre-BCR Degradation Is BiP-Dependent but l5 Unique Region-Independent
(A) Immunoblot analysis of Igm immunoprecipitates in 70Z/3 cells treated with 0.5 mg/ml SubABmut (SubAA272B) or SubAB
WT for 45 min.
(B) Translation shut-off assay of Igm in 70Z/3 cells treated with 50 mg/ml CHX together with 0.5 mg/ml SubABmut or SubABWT for the indicated times, with
quantitation shown on the right.
(C) Schematic depicting SLCs.
(D) Schematic depicting SLCs containing WT and mutant l5 (JC l5) lacking the unique region.
(E) Quantitation of MFI of intracellular levels of l5 (ic-l5) and pre-BCR in WT and Hrd1/ 70z/3 pre-B cells expressing WT or JC l5. Values are shown as
mean ± SEM.
(F) Pulse-chase analysis showing Igmdecay inWT andHrd1/ pre-B cells expressingWT or JC l5. One representative of two independent experiments is shown.
(G) A model. Sel1L-Hrd1 ERAD manages the checkpoint in B cell development by targeting the pre-BCR for cytosolic proteasomal degradation (via BiP), which
attenuates pre-BCR signaling and allows further B cell differentiation.
See also Figure S7.in B cells and that Sel1L-Hrd1 ERAD has no obvious effect on
plasma cell differentiation. Last, we show that ERAD-mediated
pre-BCR degradation requires BiP, but independent of the
unique region of l5 known to be important for the ER retention
of the pre-BCR complex.
Pre-BCR signaling marks a critical checkpoint in B cell devel-
opment. The pre-BCR signal induces a burst of proliferation of
large pre-B cells to ensure expansion of B cell precursors with
a functional Igm chain, a process known as ‘‘pre-BCR-dependent
positive selection’’ (Hess et al., 2001; van Loo et al., 2007), and,
importantly, it downregulates its own expression via silencing
the SLC genes while upregulating recombination activating
gene (Rag) expression and IgL rearrangement. Deficiency in
VpreB (Mundt et al., 2001), l5 (Kitamura et al., 1992), the trans-
membrane region of Igm (Kitamura and Rajewsky, 1992), Iga (Pe-
landa et al., 2002), and Igb (Gong and Nussenzweig, 1996) pre-
vent entry into the proliferating large pre-B cell stage and lead
to a marked enrichment of pro-B cells in the BM, resulting in aprofound decrease in mature peripheral B cells (Herzog et al.,
2009). Because Sel1L deficiency leads to a B cell developmental
block at a later stage, the molecular mechanism underlying the
defect in the Sel1LCD19 mice is unlikely to be due to loss of
function of the pre-BCR. Instead, our data demonstrate that
Sel1LCD19 mice phenocopy those of mouse models with gain-
of-function pre-BCR signaling. Persistent pre-BCR signaling
when the expression of l5 is extended (Martin et al., 2007) or
downstream negative effectors such as SLP-65 are inactivated
(Jumaa et al., 1999) leads to elevated surface pre-BCR and
continued cycling of large pre-B cells, preventing further differ-
entiation. Similarly, Sel1L deficiency in B cells results in intracel-
lular accumulation and elevated surface pre-BCR and signaling.
Consequently, Sel1LCD19 mice exhibit continued proliferation of
large pre-B cells and decreased cellularity of small pre-B cells
and mature B cells.
Expression and signaling from the pre-BCR complex are tran-
sient at the transition from the pro-B to the pre-B cell stage.Cell Reports 16, 2630–2640, September 6, 2016 2637
Downregulation of pre-BCR signaling is a prerequisite for cell-
cycle exit and further differentiation to the resting small pre-B
cell stage so that IgL gene segment rearrangement can
commence (Flemming et al., 2003; Kitamura et al., 1992; Melch-
ers, 2005; Minegishi et al., 1998; Mundt et al., 2001; Parker et al.,
2005; Shimizu et al., 2002;Wang et al., 2002). Self-limitingmech-
anisms include transcriptional silencing of SLC and dilution out
of pre-BCRs because of large pre-B cell cycling. Our data
show that the Sel1L-Hrd1 ERAD complex plays a key role in
the termination of pre-BCR signaling in B cell development.
Given the structural and composition similarity between the
pre-BCR and the BCR complexes, our findings raise an intriguing
question regarding substrate maturation in the ER and selection
by ERAD. The binding of SLC to Igm, unlike that of LC to Igm, is
likely to be much less efficient, associated more intensively
with BiP, and/or may expose folding intermediates of pre-BCR
to the ERAD machinery. This model is consistent with earlier re-
ports demonstrating that the pre-BCR complex is prone to mis-
folding and requires the activity of the ER folding machinery
(Hendershot, 1990; Minegishi et al., 1999a) and that the majority
of pre-BCR is retained in the ER, with less than 2% reaching the
cell surface comparedwith 90%of BCR reaching the cell surface
in mature B cells (Brouns et al., 1996; Fagioli and Sitia, 2001;
Fang et al., 2001; Hendershot et al., 1987; Pillai and Baltimore,
1987; Thorens et al., 1985). Moreover, the intrinsic ability of
assembled pre-BCR complexes to exit the ER is limited by the
unique region of l5 (Fang et al., 2001; Minegishi et al., 1999b;
Ohnishi and Melchers, 2003). We show in this study that,
although the unique region of l5 controls the ER exit of the
pre-BCR complex, it is dispensable for pre-BCR ERAD.
Our study demonstrates that the function of ERAD could not
be accurately predicted solely on the basis of the abundance
of secreted protein production. We speculate that this selectivity
may derive from a particularly complex requirement for the
folding of specific substrates in a cell-type-specific manner (in
this case, the pre-BCR) rather than from the extent and the
consequence of the UPR. Indeed, there was only very mild, if
any, ER stress and cell death associated with Sel1L/ERAD
deficiency in differentiating B cells. Moreover, Sel1LCD19 mice
exhibited phenotypes largely distinct from those with B cell-spe-
cific UPR deficiency (Hetz, 2012; Sha et al., 2011). For example,
Xbp1 deficiency blocks plasma cell differentiation from B cells,
whereas it has no effect on B cell development (Reimold et al.,
2001; Todd et al., 2009). IRE1a deficiency causes a severe
impairment of VDJ recombination of Ig genes, and, hence, there
is no expression of IgH and IgL chains of the BCR (Zhang et al.,
2005). This defect is associated with reduced expression of
RAG1/2 and terminal deoxynucleotidyl transferase. On the other
hand, the protein kinase RNA-like ER kinase (PERK)-eIF2a
branch of the UPR is not required for B cell differentiation (Zhang
et al., 2005). Therefore, Sel1L-Hrd1 ERADmanages B cell devel-
opment in an UPR-independent manner.
Polypeptides that do not meet the quality control standards
are retained within the ER and are recognized and retrotranslo-
cated by the ERAD machinery for proteasomal degradation in
the cytosol. Mammals possess a number of ERAD complexes,
with the Sel1L-Hrd1 complex being the most conserved and
characterized biochemically. A limited number of endogenous2638 Cell Reports 16, 2630–2640, September 6, 2016substrates of the Sel1L-Hrd1 ERAD complex have been identi-
fied in vitro, including ER luminal hedgehog, ATF6, and CD147
(Chen et al., 2011; Horimoto et al., 2013; Tyler et al., 2012).
More recently, nuclear proteins such as NRF2, Blimp1, and
PGC1b have been identified as cell-type-specific Hrd1 sub-
strates in vivo (Fujita et al., 2015; Wu et al., 2014; Yang et al.,
2014). We recently reported IRE1a as an endogenous substrate
for the Sel1L-Hrd1 ERAD in various cell types (Sun et al., 2015).
Here we show that the pre-BCR complex is an endogenous
ERAD substrate in developing B cells. Sel1L is required in this
process, likely as a key adaptor protein to stabilize Hrd1 protein,
as shown previously (Sun et al., 2014). Additionally, the physical
interaction between the pre-BCR and Sel1L suggests that Sel1L
may be intimately involved in pre-BCR turnover by recruiting
the pre-BCR complex to the ligase Hrd1. Because the pre-
BCR is the first protein complex identified as an endogenous
ERAD substrate to date, further investigation into its degradation
mechanism may shed important mechanistic insights into sub-
strate selection and protein degradation in vivo.EXPERIMENTAL PROCEDURES
Mice
Sel1Lf/f mice on the C57B6/L background have been described recently (Sun
et al., 2014) and crossed with CD19 promoter-driven Cre (CD19-Cre) mice
from Jackson Laboratory (B6.129P2(C)-Cd19tm1(cre)Cgn/J, #006785) to
generate Sel1Lf/f;CD19-Cre+ (Sel1LCD19) and control Sel1Lf/f;CD19-Cre
(Sel1Lf/f) littermates at a 1:1 ratio. Sel1Lf/+;CD19-Cre+ (Sel1LCD19/+) mice were
generated to determine the effect of Sel1L heterozygosity and the CD19-Cre
effect on B cell development. Adult 6- to 8-week-old mice were used in
most studies. In addition, Sel1LCD19 mice were crossed with Chop/
mice (B6.129S(Cg)-Ddit3tm2.1Dron/J, JAX 005530) to generate Sel1Lflox/flox;
CD19Cre+;Chop/ double knockout (Sel1LCD19;Chop/) mice. Inducible
Sel1L-deficient (Sel1LERCre) mice expressing estrogen receptor-Cre (ERCre)
fusion protein have been reported previously (Sun et al., 2014). Sel1Lf/f;
ERCre and Sel1Lf/f;ERCre+ (Sel1LERCre) littermates were used in the study.
In all studies, the CD19-Cre allele was maintained as heterozygous. Mice
were housed under specific pathogen-free conditions. Cohoused age- and
gender-matched littermates were used in all in vivo experiments. All animals
were sacrificed by cervical dislocation, and tissueswere immediately harvested.
Frozen tissues were stored at 80C. All animal procedures were approved by
the Cornell Institutional Animal Care and Use Committee (IACUC) (#2007-0051).
Flow Cytometry, Intracullar Staining, BrdU Labeling, and Antibodies
Flow cytometric analysis of peripheral immune cells was performed as we
described previously (Ji et al., 2012, 2014). To isolate BM, tibiae and femora
were isolated from mice, and BM was flushed using cold PBS supplemented
with 5% fetal bovine serum (FBS) and 1% penicillin/streptomycin. The red
blood cells (RBCs) in the BM suspension were lysed and resuspended in
cold PBS with 5% FBS and 1% penicillin/streptomycin. Cell suspensions
were stained with either 1:100 or 1:200 fluorochrome- or biotin-conjugated an-
tibodies against CD4 (GK1.5), CD8 (YTS169), Gr-1 (RB6-8C5), CD11b (M1/70),
CD45 (30-F11), CD19 (6D5), CD138 (281-2), CD2 (RM2-5), IgM (RMM-1), IgD
(11-26c.2a), CD5 (53-7.3), l5 (C-16), CD43 (1B11), VpreB (R3), pre-BCR
(SL156), avidin-PerCP, and isotype control antibodies (BioLegend or BD Bio-
sciences). Annexin V, propidium iodide, and 7-aminoactinomycin D (7-AAD)
were purchased from BioLegend and used according to the manufacturer’s
protocol. Secondary antibodies such as anti-IgG FITIC and anti-Igm phycoer-
ythrin (PE) were from Jackson ImmunoResearch. For intracellular staining,
cells were fixed and permeabilized with a BD Cytofix/Cytoperm fixation/per-
meabilization kit according to the manufacturer’s protocol. For bromodeox-
yuridine (BrdU) labeling,micewere injected intraperitoneally with BrdU (Sigma,
0.6 mg/10 g of body weight) 2 hr prior to sacrifice. BM cells were collected,
labeled with cell surface antibodies, and then fixed in cold 70% ethanol at
20C overnight. The samples were washed and digested with DNase I
(Roche, 50 U/ml in 4.2 mM MgCl2 and 150 mM NaCl) at room temperature
for 30 min. The rest of the procedures were performed as the regular flow cy-
tometric analysis using BrdU-fluorescein isothiocyanate (FITC) (PRB-1, BD
Biosciences). Samples were analyzed using a BD LSR cell analyzer at the
Flow Cytometry Core Facility at Cornell University. Data were analyzed using
CellQuest software (BD Biosciences) and Flowjo (http://www.flowjo.com).
Western Blot and Antibodies
Preparation of whole cell lysates, EndoH treatment andwestern blots were per-
formed as described previously (Sha et al., 2014; Sun et al., 2015). The anti-
bodies used in this study were as follows: Igm peroxidase (goat, 1:5,000) from
Sigma; HSP90 (rabbit, 1:6,000), BiP (goat, 1:1,000), and a-tubulin (mouse,
1:2,000) fromSanta CruzBiotechnology; Sel1L (rabbit, 1:2,000) andOS9 (rabbit,
1:10,000) from Abcam; phospho-Syk and Syk (rabbit, 1:1000) from Cell
Signaling Technology; and Calnexin (rabbit, 1:8,000) from Assay Design. The
Hrd1-specific antibody (rabbit, 1:200) was from Dr. Richard Wojcikiewicz at
State University of New York Upstate Medical University (Pearce et al., 2007).
Antibodies for Bag6 (rabbit, 1:10,000) and H2A (rabbit, 1:10,000) were a kind
gift from Dr. Yihong Ye (National Institute of Diabetes and Digestive and Kidney
Diseases [NIDDK]). Band density was quantitated using the Image Lab software
on the ChemiDOC XRS+ system (Bio-Rad). Protein levels were normalized to
HSP90 and are presented as mean ± SEM unless otherwise specified.
Pulse Labeling
4 3 106 70z/3 cells were resuspended in cysteine- and methionine-free me-
dium (Invitrogen, 21013024) for 15 min and metabolically labeled with 50 mCi
[35S]-cysteine and methionine (EasyTag, PerkinElmer) for 10 min. The labeling
was stopped by addition of 5 volumes of cold chasemedium (pre-B cell culture
medium supplemented with 5 mM L-methionine [Sigma, M5308] and 5 mM
L-cysteine [Sigma, C7352]). Cells were collected at the indicated times of
chase and lysed in 0.5% NP40 lysis buffer with n-ethylmaleimide (NEM)
(20 mM). Lysates were subjected to immunoprecipitation with Igm agarose
(Sigma). Immunoprecipitates were eluded and separated on a 7% SDS-
PAGE gel. Gels were incubated with neutralizing buffer (30% [v/v] methanol
in PBS) for 10 min and then subjected to autoradiography with X-film (Kodak).
Statistical Analysis
Results are expressed as mean ± SEM. Comparisons between groups were
made by unpaired two-tailed Student’s t test, except by one-way ANOVA
with Tukey post-test in Figure 6. All experiments were repeated at least twice
or performed with independent samples.
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